Valacyclovir |
Valtrex |
Valaciclovir Systematic (IUPAC) name 2-[(2-amino-6-oxo-3,9-dihydropurin-9-yl)methoxy] ethyl-2-amino-3-methyl-butanoate Identifiers CAS number 124832-27-5 ATC code J05AB11 PubChem 60773 DrugBank APRD00697 Chemical data Formula C13H20N6O4 Mol. weight 324.336 g/mol Pharmacokinetic data Bioavailability 55% Protein binding 13–18% Metabolism Hepatic (to aciclovir) Half life <30 minutes (valaciclovir); 2.5-3.6 hours (aciclovir) Excretion Renal 40– ...
Wikipedia - [full article]
Valacyclovir Clinical Trials
- Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00045292 - Active, not recruiting
Cancer; Infection
- A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00005663 - Active, not recruiting
Herpes Simplex; HIV Infections; Herpes Genitalis
- Valacyclovir for longterm therapy of Herpes simplex encephalitis
ClinicalTrials.gov Identifier: NCT00031486 - Recruiting
Encephalitis, Herpes Simplex
- A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
ClinicalTrials.gov Identifier: NCT00042328 - Completed
Neoplasms
- Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
ClinicalTrials.gov Identifier: NCT00297011 - Active, not recruiting
Herpes Labialis
- A Randomized Trial to Evaluate the Suppressive Effect of High-Dose Acyclovir Versus Valacyclovir on Persons With HSV-2
ClinicalTrials.gov Identifier: NCT00362297 - Recruiting
Genital Herpes
- V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
ClinicalTrials.gov Identifier: NCT00175513 - Recruiting
Psychosis
- A Study of Valacyclovir to Suppress HSV and HIV Shedding in Co-Infected Persons.
ClinicalTrials.gov Identifier: NCT00161434 - Completed
Herpes Simplex; HIV-1
- Efficacy and Safety of Famciclovir 1-Day Treatment Compared to 3-Day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
ClinicalTrials.gov Identifier: NCT00306787 - Active, not recruiting
Genital Herpes
- A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00001038 - Completed
Cytomegalovirus Infections; HIV Infections
- Valacyclovir in Immunocompromised Children
ClinicalTrials.gov Identifier: NCT00059592 - Completed
Shingles; Bone Marrow Transplantation
- The Effect of Valacyclovir on the Detection of HIV from Genital Herpes Lesions in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002404 - Completed
Herpes Simplex; HIV Infections
- Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
ClinicalTrials.gov Identifier: NCT00006131 - Completed
Herpes Zoster; Immunologic Deficiency Syndromes
- A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
ClinicalTrials.gov Identifier: NCT00002000 - Completed
Herpes Simplex; HIV Infections
- A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002084 - Completed
Herpes Simplex; HIV Infections
- VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
ClinicalTrials.gov Identifier: NCT00306293 - Completed
Genital Herpes
- Oral Valganciclovir Versus Valacyclovir
ClinicalTrials.gov Identifier: NCT00562770 - Completed
Chronic Lymphocytic Leukemia; Leukemia
- The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
ClinicalTrials.gov Identifier: NCT00001054 - Terminated
Herpes Simplex; HIV Infections; Chickenpox
- Valtrex Once Daily for Viral Shedding in Herpes Simplex Virus 2 Seropositive Subjects
ClinicalTrials.gov Identifier: NCT00116844 - Completed
Herpes Genitalis
- Controlled Trial of Valacyclovir in Infectious Mononucleosis
ClinicalTrials.gov Identifier: NCT00274404 - Completed
Infectious Mononucleosis
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding
ClinicalTrials.gov Identifier: NCT00158509 - Completed
Herpes Genitalis; HIV Infection
- Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy
ClinicalTrials.gov Identifier: NCT00561106 - Completed
Bell´s Palsy

Not Signed In -


